0001209191-18-045282.txt : 20180803 0001209191-18-045282.hdr.sgml : 20180803 20180803162717 ACCESSION NUMBER: 0001209191-18-045282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180801 FILED AS OF DATE: 20180803 DATE AS OF CHANGE: 20180803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCKENZIE W THORPE CENTRAL INDEX KEY: 0001211462 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37347 FILM NUMBER: 18992147 MAIL ADDRESS: STREET 1: 735 BROAD ST STREET 2: STE 1105 CITY: CHATTANOOGA STATE: TN ZIP: 37402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XBiotech Inc. CENTRAL INDEX KEY: 0001626878 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 512-386-2930 MAIL ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-01 0 0001626878 XBiotech Inc. XBIT 0001211462 MCKENZIE W THORPE 8201 EAST RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 1 0 1 0 Common Stock 2018-08-01 4 S 0 8163 4.2447 D 79962 I Spouse Common Stock 2018-08-02 4 S 0 30461 3.924 D 49501 I Spouse Common Stock 2018-08-03 4 S 0 23900 3.9619 D 25601 I Spouse Common Stock 11500 I Trust Common Stock 100000 I Foundation Common Stock 3898600 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.14 to $4.41, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $4.17, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.815 to $4.04, inclusive. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Effective June 29, 2018, W. Thorpe McKenzie (the "Reporting Person"), a Director of XBiotech, Inc. (the "Company"), and his spouse, Mrs. Sarah McKenzie, adopted a stock trading plan (the "10b5-1 Plan"). For personal tax and financial planning purposes, Mr. McKenzie presently intends to sell up to approximately 15% of his total holdings in the Company in monthly installments, beginning on July 30, 2018 and which will terminate on or before February 28, 2019. The 10b5-1 Plan was adopted in accordance with guidelines specified by Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, and the Company's insider trading policies. Rule 10b5-1 permits corporate officers, directors and others to adopt written, pre-arranged stock trading plans when they are not in possession of material, non-public information. Using these plans, insiders may gradually diversify their investment portfolios and spread stock trades over a period of time regardless of any material, non-public information they may receive after adopting their plans. In accordance with Rule 10b5-1, Mr. McKenzie will have no discretion over the sales of his shares of common stock under the plan. As reflected in this Form 4, the Reporting Person's spouse exercised and sold 11,875 shares of XBiotech Inc. common stock on the open market as part of this 10B5-1 trading plan. /s/ Queena Han under Power of Attorney for W. Thorpe McKenzie 2018-08-03